Endoscopic Cryotherapy for the Treatment of Epistaxis Due to Hereditary Hemorrhagic Telangiectasia

被引:4
|
作者
Kim, Joo Yeon [1 ]
Oh, Jung Ho [1 ]
Kim, Geun Tae [2 ]
Kwon, Jae Hwan [1 ]
机构
[1] Kosin Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Pusan 602702, South Korea
[2] Kosin Univ, Coll Med, Div Rheumatol, Pusan 602702, South Korea
关键词
Hereditary hemorrhagic telangiectasia; HHT; cryotherapy; POPULATION; MANAGEMENT;
D O I
10.1097/SCS.0000000000000453
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant vascular disease, involves mainly skin, mucocutaneous membranes, and viscera. Epistaxis is one of the most common symptoms of HHT, and chronic, frequently relapsing epistaxis can cause symptoms such as iron deficiency anemia, severe crusting, and nasal obstruction that can cause lower quality of life. Treatments for HHT range from medication and conservative management to more aggressive surgeries. None of the treatment options, however, have had satisfactory outcomes until now. We introduced cryotherapy for a patient with HHT and at least a 10-year history of frequent, severe epistaxis. This treatment strategy resulted in successful management of symptoms and no associated complications. We present herein a literature review and the clinical course and symptoms of an HHT patient who underwent cryotherapy.
引用
收藏
页码:E120 / E122
页数:3
相关论文
共 50 条
  • [1] Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis
    Sautter, Nathan B.
    Smith, Timothy L.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2016, 49 (03) : 639 - +
  • [2] Cauterization for epistaxis in hereditary hemorrhagic telangiectasia
    Dabiri, J.
    Fakhoury, R.
    Choufani, G.
    Mine, B.
    Hassid, S.
    B-ENT, 2016, 12 (01): : 9 - 16
  • [3] Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Hemorrhagic Telangiectasia
    Donato, Mariana
    Pimentel, Joao
    Cabral, Rui
    Escada, Pedro
    ACTA MEDICA PORTUGUESA, 2018, 31 (01): : 63 - 66
  • [4] Epistaxis in Children and Adolescents With Hereditary Hemorrhagic Telangiectasia
    Gonzalez, Cristian D.
    Mcdonald, Jamie
    Stevenson, David A.
    Whitehead, Kevin J.
    Petersen, Matthew G.
    Presson, Angela P.
    Ding, Qian
    Wilson, Kevin F.
    LARYNGOSCOPE, 2018, 128 (07) : 1714 - 1719
  • [5] Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis
    Hsu, Yuan-Pin
    Hsu, Chin-Wang
    Bai, Chyi-Huey
    Cheng, Sheng-Wei
    Chen, Chiehfeng
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (01) : 22 - 35
  • [6] The Effect of Bevacizumab (Avastin) Treatment on Epistaxis in Hereditary Hemorrhagic Telangiectasia
    Simonds, Jana
    Miller, Frank
    Mandel, Jess
    Davidson, Terence M.
    LARYNGOSCOPE, 2009, 119 (05) : 988 - 992
  • [7] Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review
    Kini, Sameer D.
    Yiu, Daniel W.
    Weisberg, Reid A.
    Davila, Juan F.
    Chelius, Daniel C.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2019, 128 (05) : 467 - 471
  • [8] Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia
    Boyer, Holly
    Fernandes, Patricia
    Le, Chap
    Yueh, Bevan
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2015, 5 (05) : 435 - 440
  • [9] An Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia
    Hoag, Jeffrey B.
    Terry, Peter
    Mitchell, Sally
    Reh, Douglas
    Merlo, Christian A.
    LARYNGOSCOPE, 2010, 120 (04) : 838 - 843
  • [10] Nd:YAG laser treatment of recurrent epistaxis in hereditary hemorrhagic telangiectasia
    Velegrakis, GA
    Prokopakis, EP
    Papadakis, CE
    Helidonis, ES
    JOURNAL OF OTOLARYNGOLOGY, 1997, 26 (06) : 384 - 386